MSD extends pharma contract with K+N

Merck Sharp & Dohme, (MSD) one of the world’s leading pharmaceutical companies, has extended its overland transport contract with Kuehne + Nagel in Europe, Middle East, Africa (EMEA) and North America for another two years.


Merck Sharp & Dohme, (MSD) one of the world’s leading pharmaceutical companies, has extended its overland transport contract with Kuehne + Nagel in Europe, Middle East, Africa (EMEA) and North America for another two years.

MSD has been using KN PharmaChain since 2012, which is a specialised supply chain solution designed for the needs of the pharmaceutical and healthcare industry. Within the scope of the cooperation Kuehne + Nagel continues to manage GXP certifi ed FTL (Full- Truck-Load) and LTL (Less-than-Truck- Load) temperature-controlled services for pharmaceutical products across the EMEA region and within North America.

In addition Kuehne + Nagel organises and executes the transportation of palletised pharmaceuticals from MSD’s manufacturing sites in Europe and North America to their global distribution centres. From that point MSD products are managed and controlled by a dedicated team of Kuehne + Nagel pharma specialists in an environment specially designed to meet the GXP guidelines.

“Kuehne + Nagel has proven to be a reliable partner that is able to meet our challenging requirements thanks to its expertise in the pharma and healthcare industry. We are confident that our collaboration will support our growth ambitions over the next years,“ commented Frederic Brut, MSD executive director global logistics.